Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis. | Academic Article |
Why?
|
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and ß-Thalassemia. | Academic Article |
Why?
|
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking. | Academic Article |
Why?
|
Glycoengineering design options for IgG1 in CHO cells using precise gene editing. | Academic Article |
Why?
|
Therapeutic in vivo delivery of gene editing agents. | Academic Article |
Why?
|
Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome. | Academic Article |
Why?
|
Mystery of the Crooked Cell 2.0: CityLab's Next Generation Socioscientific Approach to Gene Editing | Grant |
Why?
|
Mystery of the Crooked Cell 2.0: CityLab's Next Generation Socioscientific Approach to Gene Editing | Grant |
Why?
|
Mystery of the Crooked Cell 2.0: CityLab's Next Generation Socioscientific Approach to Gene Editing | Grant |
Why?
|
Mystery of the Crooked Cell 2.0: CityLab's Next Generation Socioscientific Approach to Gene Editing | Grant |
Why?
|
CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein. | Academic Article |
Why?
|
Scalable recombinase-based gene expression cascades. | Academic Article |
Why?
|
Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells. | Academic Article |
Why?
|
Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR/Cas9 Gene Editing in Mice. | Academic Article |
Why?
|
Gene-addition/editing therapy in sickle cell disease. | Academic Article |
Why?
|